Home
Conditions
Bronchial Diseases

Clinical trial condition

Bronchial Diseases

Explore clinical trials studying Bronchial Diseases. Study availability and eligibility vary by location and protocol.

4,805 public trials 452 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Diseases trial results

Completed

Investigation Of A New Medication (GW642444) In Asthmatic Patients

NCT00354874

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Wiesbaden, Hesse, Germany

GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany

GSK Investigational Site Gothenburg, Sweden

View Trial Details

Completed

Aerosol Deposition in Asthmatic Obese Women Using Heliox

NCT02620956

Conditions: Asthma, Body Weight, Bronchial Diseases, +15 more
Locations: Hospital the Federal University of Pernambuco Recife, Pernambuco, Brazil

View Trial Details

Completed

Advair Pediatric Once-Daily

NCT00920959

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Ozark, Alabama, United States

GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Little Rock, Arkansas, United States

View all 149 locations

View Trial Details

Completed

Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease

NCT00268177

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +14 more
Locations: GSK Investigational Site Aalborg, Denmark

GSK Investigational Site København NV, Denmark

GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

View all 20 locations

View Trial Details

Completed

Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate

NCT00400855

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Christchurch, New Zealand

GSK Investigational Site Wellington, New Zealand

View Trial Details

Completed

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Balmain, New South Wales, Australia

GSK Investigational Site Brisbane, Queensland, Australia

GSK Investigational Site Kippa-Ring, Queensland, Australia

GSK Investigational Site Toorak Gardens, South Australia, Australia

View all 106 locations

View Trial Details

Completed

Trial of Asthma Self-Management Education in Patients With Depressive Symptoms

NCT01708070

Conditions: Anxiety, Anxiety Disorders, Asthma, +12 more
Locations: Weill Cornell Internal Medicine Associates/Hospital for Special Surgery New York, United States

View Trial Details

Completed

Implementation of a Pediatric-to-adult Asthma Transition Program

NCT01521247

Conditions: Asthma, Bronchial Diseases, Education, +7 more
Locations: Calgary Regional Pediatric Asthma Clinic Calgary, Alberta, Canada

View Trial Details

Completed

Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients

NCT02427165

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Skane University Hospital Lund, Sweden

Celerion Belfast, United Kingdom

View Trial Details

Completed

Grazax Asthma Prevention

NCT01061203

Conditions: Allergic Rhinitis, Asthma, Bronchial Diseases, +13 more
Locations: Terveystalo Turku Turku, Finland

View Trial Details

Bronchial Diseases

Bronchial Diseases trial results

Related conditions